DD

Systematic screening of DuPont De Nemours reveals a materials science leader navigating substantial operational headwinds, with profitability metrics materially compressed during a cyclical downturn. The company's negative ROE of -0.16% and net margin of -0.3% reflect earnings under pressure, while the TTM EPS of -$0.07 indicates near-breakeven performance. The 52-week price range of $11.36 to $52.66 illustrates extreme volatility, with the current $48.64 valuation approaching recent highs despite challenged fundamentals.

The balance sheet demonstrates notable resilience through the downturn. The debt-to-equity ratio of 0.23 positions DD among the least leveraged major chemical manufacturers, while the current ratio of 2.42 signals strong near-term liquidity coverage. The price-to-book ratio of 1.21 trades at a modest premium to book value of $34.02 per share, suggesting the market prices in recovery potential beyond tangible asset value. The $20.2 billion market capitalization reflects mid-tier positioning within diversified chemicals.

Key fundamental concerns center on revenue contraction and margin compression. The year-over-year revenue decline of -22.51% represents significant demand weakness across end markets, while the operating margin of 10.12% indicates pressure on pricing power. The gross margin of 37.23% suggests some intermediate profitability preservation despite top-line challenges.

Research perspective relative to peers SHW, ECL, and PPG highlights DD's cyclical exposure versus more defensively-positioned specialty chemical competitors. The beta of 0.93 indicates slightly below-market volatility, though recent price action suggests higher realized volatility. The model flags liquidity strength and deleveraged capital structure as primary differentiators during this fundamental trough.